These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 19862667

  • 21. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
    Umpierrez G, Issa M, Vlajnic A.
    Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
    [Abstract] [Full Text] [Related]

  • 22. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
    Bays HE.
    Endocr Pract; 2011 Apr; 17(6):933-8. PubMed ID: 21856592
    [Abstract] [Full Text] [Related]

  • 23. Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 diabetes mellitus.
    Jain R, Osei K, Kupfer S, Perez AT, Zhang J.
    Pharmacotherapy; 2006 Oct; 26(10):1388-95. PubMed ID: 16999648
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 25. Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension.
    Tzimos A, Samokhvalov V, Kramer M, Ford L, Gassmann-Mayer C, Lim P, Eerdekens M.
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):31-43. PubMed ID: 18165460
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A, Wyndaele JJ, Sieber P.
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of colesevelam in combination with pioglitazone in patients with type 2 diabetes mellitus.
    Rosenstock J, Truitt KE, Baz-Hecht M, Ford DM, Tao B, Chou HS.
    Horm Metab Res; 2014 Dec; 46(13):943-9. PubMed ID: 25054436
    [Abstract] [Full Text] [Related]

  • 28. Clinical efficacy of colesevelam in type 2 diabetes mellitus.
    Brunetti L, Campbell RK.
    J Pharm Pract; 2011 Aug; 24(4):417-25. PubMed ID: 21813819
    [Abstract] [Full Text] [Related]

  • 29. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
    Bays HE, Goldberg RB, Truitt KE, Jones MR.
    Arch Intern Med; 2008 Oct 13; 168(18):1975-83. PubMed ID: 18852398
    [Abstract] [Full Text] [Related]

  • 30. Colesevelam hydrochloride for the treatment of type 2 diabetes mellitus.
    Sonnett TE, Levien TL, Neumiller JJ, Gates BJ, Setter SM.
    Clin Ther; 2009 Feb 13; 31(2):245-59. PubMed ID: 19302898
    [Abstract] [Full Text] [Related]

  • 31. Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus.
    Levy P.
    Metab Syndr Relat Disord; 2010 Dec 13; 8 Suppl 1():S9-13. PubMed ID: 20946010
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of colesevelam, rosiglitazone, or sitagliptin on glycemic control and lipid profile in patients with type 2 diabetes mellitus inadequately controlled by metformin monotherapy.
    Rigby SP, Handelsman Y, Lai YL, Abby SL, Tao B, Jones MR.
    Endocr Pract; 2010 Dec 13; 16(1):53-63. PubMed ID: 19789153
    [Abstract] [Full Text] [Related]

  • 36. Long-term (52-78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients.
    Bays HE.
    Diabetes Metab Syndr Obes; 2012 Dec 13; 5():125-34. PubMed ID: 22807633
    [Abstract] [Full Text] [Related]

  • 37. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
    Rosenstock J, Fonseca VA, Garvey WT, Goldberg RB, Handelsman Y, Abby SL, Lai YL, Jin X, Misir S, Nagendran S, Jones MR.
    Endocr Pract; 2010 Dec 13; 16(4):629-40. PubMed ID: 20634175
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes.
    Rosenson RS, Abby SL, Jones MR.
    Atherosclerosis; 2009 Jun 13; 204(2):342-4. PubMed ID: 18996525
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.